Journal of Periodontal and Implant Science

  • 제50권3호
  • /
  • Pages.135-145
  • /
  • 2020
  • /
  • 2093-2278(pISSN)
  • /
  • 2093-2286(eISSN)
대한치주과학회 (Korean Academy of Periodontology)
권호 표지
DOI QR코드

DOI QR Code

Is the relationship between periodontitis and hyperlipidemia mediated by lipoprotein-associated inflammatory mediators?

  • 투고 : 2019.07.07
  • 심사 : 2020.04.01
  • 발행 : 2020.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The aim of this study was to evaluate the serum levels of oxidized low-density lipoprotein (oxLDL), anti-oxLDL, and myeloperoxidase (MPO) in hyperlipidemic patients with periodontal disease. Methods: This study included 123 patients with hyperlipidemia categorized based on metabolic control as mild to moderate (H1) (n=66) or poor (H2) (n=57), as well as systemically healthy controls (C) (n=68). Serum levels of lipids, oxLDL, anti-oxLDL, and MPO were evaluated, along with clinical periodontal parameters. Results: The percentage of bleeding on probing (BOP%) and the clinical attachment level were significantly higher in the H2 group than in the C group. Patients with hyperlipidemia had a relatively high risk of developing periodontal disease. The oxLDL and anti-oxLDL levels were higher in H2 patients with periodontitis than in the control or H1 patients with periodontitis. In the H1 and H2 groups, the ratio of total cholesterol to high-density lipoprotein was significantly correlated with gingival index, BOP%, and oxLDL levels. Conclusions: Our findings indicate that the lipoprotein-associated inflammatory mediators of oxLDL, anti-oxLDL, and MPO may play an important role in the relationship between periodontal disease and hyperlipidemia.

키워드

참고문헌

  1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. https://doi.org/10.1016/S0140-6736(04)17018-9
  2. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005;353:46-57. https://doi.org/10.1056/NEJMoa043175
  3. D'Aiuto F, Orlandi M, Gunsolley JC. Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Periodontol 2013;84:S85-105. https://doi.org/10.1902/jop.2013.134007
  4. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol 2013;84:S70-84. https://doi.org/10.1902/jop.2013.134008
  5. Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P, et al. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J Am Coll Cardiol 2014;63:1724-34. https://doi.org/10.1016/j.jacc.2013.12.030
  6. Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 2000;20:1536-42. https://doi.org/10.1161/01.ATV.20.6.1536
  7. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211-7. https://doi.org/10.1038/nm1102-1211
  8. Itabe H. Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis. J Clin Biochem Nutr 2012;51:1-8. https://doi.org/10.3164/jcbn.11-00020R1
  9. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990;87:5134-8. https://doi.org/10.1073/pnas.87.13.5134
  10. Delporte C, Van Antwerpen P, Vanhamme L, Roumeguere T, Zouaoui Boudjeltia K. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm 2013;2013:971579.
  11. Sokolov AV, Kostevich VA, Runova OL, Gorudko IV, Vasilyev VB, Cherenkevich SN, et al. Proatherogenic modification of LDL by surface-bound myeloperoxidase. Chem Phys Lipids 2014;180:72-80. https://doi.org/10.1016/j.chemphyslip.2014.02.006
  12. Steinerova A, Racek J, Stozicky F, Zima T, Fialova L, Lapin A. Antibodies against oxidized LDL--theory and clinical use. Physiol Res 2001;50:131-41.
  13. Buhlin K, Gustafsson A, Pockley AG, Frostegard J, Klinge B. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003;24:2099-107. https://doi.org/10.1016/j.ehj.2003.09.016
  14. Teeuw WJ, Slot DE, Susanto H, Gerdes VE, Abbas F, D'Aiuto F, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. J Clin Periodontol 2014;41:70-9. https://doi.org/10.1111/jcpe.12171
  15. Fitzsimmons TR, Sanders AE, Bartold PM, Slade GD. Local and systemic biomarkers in gingival crevicular fluid increase odds of periodontitis. J Clin Periodontol 2010;37:30-6. https://doi.org/10.1111/j.1600-051X.2009.01506.x
  16. Fentoglu O, Koroglu BK, Kara Y, Dogan B, Yilmaz G, Sutcu R, et al. Serum lipoprotein-associated phospholipase A2 and C-reactive protein levels in association with periodontal disease and hyperlipidemia. J Periodontol 2011;82:350-9. https://doi.org/10.1902/jop.2010.100417
  17. Fentoglu O, Koroglu BK, Hicyilmaz H, Sert T, Ozdem M, Sutcu R, et al. Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol 2011;38:8-16. https://doi.org/10.1111/j.1600-051X.2010.01644.x
  18. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-35. https://doi.org/10.3109/00016356408993968
  19. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-51. https://doi.org/10.3109/00016356309011240
  20. Chapple IL, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol 2018;89 Suppl 1:S74-84. https://doi.org/10.1002/JPER.17-0719
  21. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Clin Periodontol 2018;45 Suppl 20:S149-61. https://doi.org/10.1111/jcpe.12945
  22. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39. https://doi.org/10.1161/01.CIR.0000133317.49796.0E
  23. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci U S A 1986;83:2704-8. https://doi.org/10.1073/pnas.83.8.2704
  24. Naito HK. The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography. Ann N Y Acad Sci 1985;454:230-8. https://doi.org/10.1111/j.1749-6632.1985.tb11862.x
  25. Maglakelidze N, Galogre A, Tsagareli Z. Functional-morphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia. Georgian Med News 2005:71-4.
  26. Penumarthy S, Penmetsa GS, Mannem S. Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients. J Indian Soc Periodontol 2013;17:30-5. https://doi.org/10.4103/0972-124X.107471
  27. Turkoglu O, Baris N, Kutukculer N, Senarslan O, Guneri S, Atilla G. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. J Periodontol 2008;79:332-40. https://doi.org/10.1902/jop.2008.070321
  28. Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M. Periodontal treatment decreases plasma oxidized LDL level and oxidative stress. Clin Oral Investig 2011;15:953-8. https://doi.org/10.1007/s00784-010-0458-y
  29. Shah R, Thomas R, Mehta DS. Oxidized-low density lipoprotein in gingival crevicular fluid of patients with chronic periodontitis: a possible link to atherogenesis. Acta Odontol Scand 2014;72:154-6. https://doi.org/10.3109/00016357.2013.810772
  30. Miyasaki KT. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 1991;62:761-74. https://doi.org/10.1902/jop.1991.62.12.761
  31. Van Dyke TE, Horoszewicz HU, Cianciola LJ, Genco RJ. Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun 1980;27:124-32. https://doi.org/10.1128/iai.27.1.124-132.1980
  32. Jovinge S, Ares MP, Kallin B, Nilsson J. Human monocytes/macrophages release TNF-alpha in response to ox-LDL. Arterioscler Thromb Vasc Biol 1996;16:1573-9. https://doi.org/10.1161/01.ATV.16.12.1573
  33. Dutta-Roy AK. Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 1994;51:385-99. https://doi.org/10.1016/0952-3278(94)90054-X
  34. Nicholls SJ, Hazen SL. Myeloperoxidase, modified lipoproteins, and atherogenesis. J Lipid Res 2009;50 Suppl:S346-51. https://doi.org/10.1194/jlr.R800086-JLR200
  35. Boudjeltia KZ, Delporte C, Van Antwerpen P, Franck T, Serteyn D, Moguilevsky N, et al. Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men. Mediators Inflamm 2013;2013:750742.
  36. Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM. Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 2013;93:185-98. https://doi.org/10.1189/jlb.0712349
  37. Kinane DF, Lappin DF. Immune processes in periodontal disease: a review. Ann Periodontol 2002;7:62-71. https://doi.org/10.1902/annals.2002.7.1.62
  38. Fentoglu O, Sozen T, Oz SG, Kale B, Sonmez Y, Tonguc MO, et al. Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment. Oral Dis 2010;16:648-54. https://doi.org/10.1111/j.1601-0825.2010.01668.x
  39. Petersen KS, Clifton PM, Keogh JB. The association between carotid intima media thickness and individual dietary components and patterns. Nutr Metab Cardiovasc Dis 2014;24:495-502. https://doi.org/10.1016/j.numecd.2013.10.024